Clinical Trial: Clinical Study on the Amelioration of Endocrine and Metabolic Abnormalities in Patients with PCOS through Oral Administration of Lycium barbarum Glycopeptide (China)

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study on the Amelioration of Endocrine and Metabolic Abnormalities in Patients with PCOS through Oral Administration of Lycium barbarum Glycopeptide'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130429

Registration Time: 2026/08/19

Type: Interventional study

Primary Sponsor: Peking University First Hospital Ningxia Women And Children’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=302553

Published by HT Digital Content Services with permission from Health Daily Digest....